Study examines safety and effectiveness of infliximab biosimilar in patients with inflammatory bowel

Biosimilars are biologic agents that highly similar to original biomedical medications (oringinators), but are much cheaper. …read more

Source: EurekAlert

(Visited 6 times, 1 visits today)

Popular Posts